Physician profile

Anthony A Smith

Plastic Surgery · Phoenix, AZ

NPI 1043295561

$953.89

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$305.82

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Axogen $203.38 2022-2024 Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector
Innovation Technologies INC $133.79 2022
Acell, INC. $125.10 2019
Osteocentric Technologies, INC. $121.80 2024 Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St
Endo Pharmaceuticals INC. $121.65 2022
Trimed, INC. $106.06 2022
Zimmer Biomet Holdings, INC. $95.23 2023 Ncb
Integra Lifesciences Corporation $46.88 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Anthony A Smith

$953.89

in general payments reported 2019-2025

Years
2019-2024
Top company
Axogen

https://glasscript.com/doctor/137491/anthony-a-smith

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.